Weaker Dollar Squeezes U.S. Libraries

WASHINGTON—A weaker dollar is forcing American research libraries to pay much higher prices this year for books and journals published overseas—if they can afford them at all. As a result, U.S. scientists soon may find it increasingly difficult to keep up with the latest developments in their fields. In the past 18 months the dollar has slipped more than 40 percent against the Japanese yen and several major European currencies. The resulting price increases, on top of those owing to

Written byStephen Greene
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the past 18 months the dollar has slipped more than 40 percent against the Japanese yen and several major European currencies. The resulting price increases, on top of those owing to inflation, are tearing large holes in library acquisition budgets.

The situation has become "one of the greatest concerns of our member libraries," said Jaia Barrett, federal relations officer of the Association of Research Libraries in Washington.

The cost of a full subscription to Biochimica et Biophysica Acta, which is published by the Dutch firm Elsevier, has risen from $2,698 last year to $3,540, according to Chuck Hamaker, assistant director for collection development at Louisiana State University. Applied Catalysis, also published by Elsevier, costs $916 this year compared with $608 a year ago.

"Any academic library is feeling [the budgetary crunch] to some extent, but the larger the library and the more extensive its collection and its emphasis on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies